Medical Condition News

RSS

Innovative CAR-T cells effectively target glioblastoma with reduced toxicity

Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than two years, and against which current treatments remain ineffective.

26 Sep 2024

Brief behavioral intervention reduces intrusive memories of trauma in healthcare workers post-COVID-19

Researchers examine whether a cognitive task can reduce intrusive memories in healthcare workers exposed to traumatic experiences during the pandemic.

26 Sep 2024

Maternal obesity doubles the risk of developing autism in children

Researchers investigate the potential relationship between maternal fat mass and long-term mental health issues in children born to these mothers.

26 Sep 2024

Weekend warrior exercise linked with lower risk of developing 264 diseases

Busy with work and other obligations, some people concentrate their moderate-to-vigorous exercise in one or two days of the week or weekend.

26 Sep 2024

New discovery could lead to improved treatments for age- and cancer-related muscle degeneration

With the global population aging rapidly, sarcopenia, a condition that affects millions of older adults and severely diminishes their quality of life, is emerging as an urgent public health issue.

26 Sep 2024

Nursing aides plagued by PTSD after ‘nightmare’ covid conditions, with little help

One evening in May, nursing assistant Debra Ragoonanan's vision blurred during her shift at a state-run Massachusetts veterans home.

26 Sep 2024

Targeted drug therapy shows promise for ulcerative colitis remission

An international placebo-controlled study led by Cedars-Sinai suggests that a targeted drug therapy that was developed by researchers at Cedars-Sinai is safe and effective at helping people with moderate to severe ulcerative colitis reach clinical remission.

26 Sep 2024

Understanding the role of TIPS in improving renal function amid cirrhosis

Cirrhosis is one of the leading causes of mortality from non-communicable diseases, with complications arising as liver function deteriorates.

26 Sep 2024

Targeting tumor immunity with transferrin receptor-directed photodynamic therapy

This new article publication from Acta Pharmaceutica Sinica B, discusses a transferrin receptor-targeted immunostimulant for photodynamic immunotherapy against metastatic tumors through β-catenin/CREB interruption.

26 Sep 2024

Childhood obesity: How the first 2,000 days hold the key to lifelong health

Researchers reveal that early life factors, especially within the first 2,000 days, play a critical role in shaping future obesity risk. Addressing these factors with integrated interventions could combat the global childhood obesity crisis.

26 Sep 2024

Noninvasive imaging reveals impact of diet on cardiovascular health

The dynamics of blood nutrient and lipid levels after consuming a high-fat meal are crucial indicators of both current and future cardiovascular health. Traditionally, measuring these circulating substances has involved invasive blood draws, which are not feasible for regular health tracking.

26 Sep 2024

COVID-19 causes lasting cognitive impairment tied to brain injury markers

Researchers found that COVID-19 patients experienced widespread cognitive deficits one year post-hospitalization, associated with elevated brain injury markers and reduced brain volume. Cognitive recovery plateaued over time, suggesting lasting impacts.

26 Sep 2024

Barcoding technology reveals secrets of cancer metastasis

Metastatic cancer can be a devastating diagnosis. The cancer is spreading. It may travel to multiple organs in the body. This could mean more pain and ultimately, death.

26 Sep 2024

Multi-omics analysis reveals mechanism of action for ruthenium-based anti-cancer agent

This study is led by Prof. Cai-Ping Tan, Prof. Zong-Wan Mao (MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, School of Chemistry, Sun Yat-Sen University) and Prof. Zheng-Qiu Li (School of Pharmacy, MOE Key Laboratory of Tumor Molecular Biology, Jinan University).

26 Sep 2024

Researchers explore new metabolic pathway to fight cancer

When an aggressive cancer launches an invasion on the human body, anything that can be done to slow down or better understand that fast-paced assault is going to be a bonus.

26 Sep 2024

Foundation receives $100,000 to advance MS care

The Foundation of the Consortium of Multiple Sclerosis Centers (FCMSC) recently received a generous donation of $100,000 from EMD Serono Inc., in honor of June Halper, MSN, APN-C, FAAN, MSCN. Ms. Halper a longtime pioneer in the comprehensive care movement for multiple sclerosis (MS), and leading nurse practitioner and MS advocate, passed away on July 24, 2024, at the age of 86, working until her final days as CEO of the CMSC, FCMSC and IOMSN (International Organization of MS Nurses).

26 Sep 2024

New pipeline of drug candidates offers hope for effective MASLD treatments

Non-alcoholic fatty liver disease (NAFLD), recently reclassified as metabolic dysfunction-associated steatotic liver disease (MASLD), has become the most prevalent chronic liver disease globally.

25 Sep 2024

Study uncovers genetic changes linked to leukemia risk in people with Down's syndrome

People with Down's syndrome face a higher risk of developing Leukemia. Now researchers from the University of Copenhagen and Stanford University explain why, by identifying specific changes in blood cells of people with Down's syndrome.

25 Sep 2024

Research highlights negative brain health outcomes among LGBTQ+ individuals

LGBTQ+ people may be more likely to have negative brain health outcomes, including a higher risk of dementia and late-life depression, than people who are cisgender and straight, according to a study published in the September 25, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

25 Sep 2024

Study reveals life-changing impact of gene therapy for hemophilia B patients

Adults with hemophilia B saw their number of bleeding episodes drop by an average of 71 percent after a single infusion of gene therapy, according to the results of an international Phase III clinical trial published today in the New England Journal of Medicine by researchers from the University of Pennsylvania Perelman School of Medicine and a multicenter group of investigators.

25 Sep 2024